Ian Mortimer sells 270,000 XENE shares; multiple disposals (NASDAQ: XENE)

Rhea-AI Filing Summary

Ian Mortimer reported dispositions of Common Shares. The filing lists sales of 40,000 shares on 01/02/2026, 270,000 shares on 03/09/2026, and 11,269 shares on 03/10/2026. It also shows a 12,500 restricted share unit award vesting on 03/12/2026.

Insights

Equity Capital Markets Analyst

Multiple insider dispositions were reported across early 2026.

Reported transactions show three dispositions by Ian Mortimer totaling 321,269 shares across 01/02/2026

The filing also records a 12,500 RSU vesting on 03/12/2026. Cash‑flow treatment and whether sales were market trades or part of a plan are not stated in the provided excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Morgan Stanley Wealth Management Canada Inc. Suite 1500, 600 - 3 Avenue SW Calgary Z4 T2P 0G5	7308	403583	83190316	03/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	03/12/2026	Restricted share unit award vesting	Issuer			12500	03/12/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ian Mortimer 3650 Gilmore Way Burnaby A1 V5G 4W8	Common Shares	01/02/2026	40000	1777166
Ian Mortimer 3650 Gilmore Way Burnaby A1 V5G 4W8	Common Shares	03/09/2026	270000	16289196
Ian Mortimer 3650 Gilmore Way Burnaby A1 V5G 4W8	Common Shares	03/10/2026	11269	677357

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What sales did Ian Mortimer report for XENE?

He reported sales of 40,000, 270,000, and 11,269 Common Shares. The sales occurred on 01/02/2026, 03/09/2026, and 03/10/2026, respectively, as shown in the filing.

Did the filing show any vested restricted share units for XENE?

Yes. The filing shows a restricted share unit award vesting of 12,500 Common Shares on 03/12/2026. The entry is listed under securities to be sold as an issuer vesting event.

Who is listed as the issuer or broker in the Form 144 excerpt?

The excerpt lists Morgan Stanley Wealth Management Canada Inc. with an address in Calgary. This appears under the securities information section in the provided content.

Does the filing state proceeds or sale method for the reported transactions?

The provided excerpt does not state proceeds or the method of sale. It lists transaction dates and share counts only; cash‑flow details and sale mechanics are not included in the visible text.

What is the total number of shares shown as sold in the excerpt?

The three reported dispositions sum to 321,269 Common Shares. These comprise 40,000, 270,000, and 11,269 reported on the listed dates in early 2026.